2m 2m 2m 2m 2m 2m 2m
Cytosorbents (CTSO)
NASDAQ
$0.37+$0.007 (+1.97%)
Price as of Aug 03, 2026 4:10 PM EDT- $22.7MMarket Cap
- -58.48%1-Year Change
- Medical DevicesIndustry
Cytosorbents (CTSO)
$0.37+$0.007 (+1.97%)
CTSO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.36 | ||
Change | +$0.01 (+3.08%) | ||
Open | $0.38 | ||
High | $0.39 | ||
Low | $0.35 | ||
Previous Close | $0.35 | ||
Volume | 88,331 | ||
30-Day Average Volume | 66,702 | ||
1-Week Change | 0.25% | ||
1-Month Change | -3.50% | ||
1-Year Change | -58.48% | ||
3-Year Change | -89.89% | ||
5-Year Change | -95.26% | ||
Fundamentals | |||
Shares Outstanding | 62.8M | ||
Total Assets | $40.6M | ||
Market Cap | $22.7M | ||
Enterprise Value | $34.8M | ||
Period: QTR TTM FY | |||
Revenue | $8.9M | ||
Net Income | -$5.1M | ||
Free Cash Flow | -$1.2M | ||
EBIT | -$4.3M | ||
EBITDA | -$4.2M | ||
Net Working Capital | $1.5M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 10 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 12/05/2014 | ||
Earnings & Revenue